GL1X · GenesisL1 explorer

MolNFT v1 · #61691 · protein

Engineered human lipocalin 2 in complex with Y-dtpa

3DSZ: “Engineered human lipocalin 2 in complex with Y-dtpa”. X-ray diffraction, 2 ligands (LIZ, YT3), 4 pockets (best druggability 0.73). MolNFT v1 #61691 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3DSZ
Type
protein
Length
345 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Engineered human lipocalin 2
Ligands
LIZ, YT3
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEngineered human lipocalin 2protein17215% helix, 44% strand—
BEngineered human lipocalin 2protein17317% helix, 43% strand—

Ligands and binding sites

  • LIZ · N-{(1S,2S)-2-[bis(carboxymethyl)amino]cyclohexyl}-N-{(2R)-2-[bis(carboxymethyl)amino]-3-[4-({[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]carbamothioyl}amino)phenyl]propyl}glycine · ligand · 2 copies · chains A, B
  • YT3 · Yttrium (III) ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17450.730.7951LIZ, YT3
26410.680.7749LIZ, YT3
31820.470.7625empty
4870.360.7517empty

Interfaces

1 interface between chains.

  • A–B · 333 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 3DSZ · Engineered human lipocalin 2 in complex with Y-DTPA · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.